DefinePK hosts the largest index of Pakistani journals, research articles, news headlines, and videos. It also offers chapter-level book search.
Title: Minor Oral Surgery with Out Stopping the Daily Low Dose of Aspirin Therapy
Authors: Batool Sajjad, Sehrish Choudhry, Sabeen Masood, Zafar Abbas, Hasham Aleem, Syed Akbar Abbas Zaidi
Journal: Journal of Gandhara Medical and Dental Sciences (JGMDS)
Publisher: Gandhara University, Peshawar
Country: Pakistan
Year: 2023
Volume: 10
Issue: 2
Language: English
Keywords: Oral SurgeryAspirinBleeding timelow dose
OBJECTIVES
Patients with the low-dose long-term aspirin regime have a severe risk of excessive bleeding during surgery, placing them at risk of "adverse thrombotic events". This study aims to evaluate the bleeding in patients undergoing minor oral surgery procedures without stopping daily low-dose aspirin therapy.
METHODOLOGY
A descriptive cross-sectional hospital-based investigation involved the patient with minor oral surgery at "Altamash Institute of Dental Medicine, Karachi, Pakistan" from mid-April 2021 to mid-June 2021, who were between the age group 30 to 75 with a low-dose aspirin regime. The data was collected via a questionnaire to record the variables, i.e. duration of aspirin, postoperative medications, platelets count, clotting time, normal bleeding time, and intraoperative bleeding time.
RESULTS
51 patients, of which 32 were males while 19, were females. The normal bleeding time was comparatively analyzed with the intraoperative bleeding time using SPSS statistical software version 22. The results revealed that the mean bleeding time for the patients with a low-dose aspirin regime during minor oral surgery was 5.49 ± 1.07, while for the patients with a stopped aspirin dose was 4.57 ± 1.07. The comparative analysis using a t-test doesn't reveal significant statistical differences of p<0.05 between both groups.
CONCLUSION
We concluded that minor oral surgical procedures could safely be done without altering or stopping the low-dose, long-term aspirin regime.
To evaluate the bleeding in patients undergoing minor oral surgery procedures without stopping daily low-dose aspirin therapy.
A descriptive cross-sectional hospital-based study was conducted from mid-April to mid-June 2021 at the Altamash Institute of Dental Medicine, Karachi, Pakistan. Participants were between 30 and 75 years old, on long-term low-dose aspirin (75-100 mg), and required minor oral surgery. Data was collected via a questionnaire and included duration of aspirin use, postoperative medications, platelet count, clotting time, normal bleeding time, and intraoperative bleeding time. Patients were divided into two groups: those continuing aspirin and those who stopped it. SPSS statistical software version 22 was used for data analysis.
graph TD
A["Patient Recruitment 30-75 yrs, low-dose aspirin, minor oral surgery"] --> B["Preoperative Evaluation"Bleeding time, Platelet count""];
B --> C["Data Collection"Questionnaire""];
C --> D["Divide into Groups"Continue Aspirin vs. Stop Aspirin""];
D --> E["Perform Minor Oral Surgery"];
E --> F["Postoperative Monitoring & Follow-up"];
F --> G["Data Analysis SPSS v22"];
G --> H["Compare Bleeding Times"];
H --> I["Conclusion"];
The study supports the continuation of low-dose aspirin therapy during minor oral surgery, as it does not lead to significantly increased bleeding. Discontinuing aspirin can pose a risk of thromboembolism in patients with cardiovascular conditions. The findings align with other studies suggesting that minor oral surgical procedures can be safely performed without altering aspirin regimens.
The mean bleeding time for patients continuing low-dose aspirin during minor oral surgery was 5.49 ± 1.07, while for patients who stopped aspirin, it was 4.57 ± 1.07. A t-test analysis did not reveal significant statistical differences (p<0.05) between the two groups regarding bleeding time.
Minor oral surgical procedures can be safely performed without altering or stopping the low-dose, long-term aspirin regime.
1. Study Period: The study was conducted from mid-April 2021 to mid-June 2021. (Confirmed)
2. Participant Age Range: Participants were between the age group of 30 to 75 years. (Confirmed)
3. Number of Participants: 51 patients were selected for the research. (Confirmed)
Loading PDF...
Loading Statistics...